頭頸部がんにおけるフェロプトーシスの現在の見通しと動向: 文献測定分析
Jin Pan1, Yi Zhang1, Binbin Zhao1
1Key Laboratory of Oral Diseases Research of Anhui Province, College & Hospital of Stomatology, Anhui Medical University, Hefei, China.
Frontiers in oral health
|August 27, 2025
まとめ
鉄に依存する細胞死であるフェロプトーシスは 癌において極めて重要です この文献分析は,頭頸部がんの研究の動向をマッピングし,将来の研究のための主要な貢献者と新興トピックを特定します.
科学分野:
- 生物医学
- 腫瘍学
- 細胞生物学
背景:
- フェロプトーシスとは,鉄に依存した制御された細胞死であり,鉄の蓄積と脂質過酸化を伴う.
- 癌,神経変性疾患,心血管疾患など様々な疾患に 関わっている.
- 頭頸部がんにおけるフェロプトーシスに関する研究は,傾向と寄与因子の体系的な分析が欠けている.
研究 の 目的:
- 頭頸部がんにおけるフェロプトーシスの研究に関する文献分析を行う.
- 研究のホットスポット,主要な貢献者,新興傾向を特定する.
- 将来の研究のための包括的な概要と参考文献を提供する.
主な方法:
- Web of Science Core Collection (ウェブ・オブ・サイエンス・コア・コレクション) の出版物に関する文献測定分析 (2016年1月 - 2025年3月)
- VOSviewerとCiteSpaceを使用してデータの可視化とマッピング.
- 出版物,国,雑誌,キーワードの分析
主要な成果:
- 19か国から110の出版物があり,中国がトップ (76.36%) です.
- トップのジャーナルには Nature,Cell,Cancer Lettersなどがあります.
- 新興キーワード:発現,細胞死,フェロプトーシス,抑制,代謝,治療
結論:
- この研究は,頭頸部がんにおけるフェロプトーシスの研究傾向の包括的な概要を提供します.
- 重要な研究領域と新興テーマ分野を強調しています.
- 発見は,この分野の研究者にとって貴重な参考になります.
関連する概念動画
Necrosis
4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


